tiprankstipranks
Trending News
More News >
Clearpoint Neuro, Inc. (CLPT)
:CLPT
US Market
Advertisement

ClearPoint Neuro (CLPT) Earnings Dates, Call Summary & Reports

Compare
391 Followers

Earnings Data

Report Date
Mar 04, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.2
Last Year’s EPS
-0.2
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted several strategic advancements, including a merger with IRRAS and revenue growth across key segments. However, challenges such as increased operating expenses and a temporary slowdown in revenue growth due to facility transitions were noted. Overall, the strategic positioning and growth initiatives suggest a positive outlook.
Company Guidance
During the call, ClearPoint Neuro outlined its strategic guidance for fiscal year 2025 and beyond, focusing on two main growth strategies. The "Fast Forward" phase targets existing markets totaling over $1 billion, aiming for a credible path to cash breakeven and meaningful profitability. The "Essential Everywhere" phase seeks to build a new $10 billion-plus addressable market in neuro drug delivery with pharma partners. The company announced a merger with IRRAS, expected to close in Q4 2025, which should enhance operational scale and market reach. ClearPoint reported Q3 2025 revenue of $8.9 million, a 9% increase from the previous year, with a gross margin of 63%. The merger involves a $5 million cash consideration and 1,325,000 shares of ClearPoint's stock, with additional funding of $20 million secured. The company anticipates 2026 combined revenue of $54 million to $60 million, leveraging a commercial team of over 50 professionals and significant market opportunities in neurosurgery and drug delivery.
Merger with IRRAS
ClearPoint Neuro announced a merger agreement with IRRAS, expected to close in Q4 2025. The merger provides access to a $0.5 billion market in intracranial fluid management and expands the commercial team by over 40 professionals.
Revenue Growth
ClearPoint Neuro reported a 9% increase in total revenue for Q3 2025, reaching $8.9 million compared to $8.1 million in Q3 2024.
Neurosurgery Navigation Revenue Increase
The neurosurgery navigation segment grew by 20% to $3.4 million in Q3 2025, driven by higher sales of PRISM Laser Therapy and the introduction of new navigation software.
Capital Equipment and Software Growth
Revenue from capital equipment and software increased by 25% to $1 million in Q3 2025.
Increased Gross Margin
Gross margin improved to 63% in Q3 2025 from 60% in Q3 2024.
Strong Cash Position
ClearPoint Neuro's cash and cash equivalents increased to $38.2 million as of September 30, 2025, up from $20.1 million at the end of 2024.
New CRO Facility
ClearPoint transitioned to a new CRO facility in Torrey Pines, expected to lead to double-digit growth in biologics and drug delivery in Q4 2025 and beyond.

ClearPoint Neuro (CLPT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CLPT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 04, 2026
2025 (Q4)
-0.20 / -
-0.2
Nov 06, 2025
2025 (Q3)
-0.20 / -0.21
-0.18-16.67% (-0.03)
Aug 12, 2025
2025 (Q2)
-0.20 / -0.21
-0.16-31.25% (-0.05)
May 13, 2025
2025 (Q1)
-0.16 / -0.22
-0.16-37.50% (-0.06)
Feb 26, 2025
2024 (Q4)
-0.16 / -0.20
-0.18-11.11% (-0.02)
Nov 07, 2024
2024 (Q3)
-0.17 / -0.18
-0.210.00% (+0.02)
Aug 07, 2024
2024 (Q2)
-0.20 / -0.16
-0.2944.83% (+0.13)
May 07, 2024
2024 (Q1)
-0.19 / -0.16
-0.2330.43% (+0.07)
Mar 12, 2024
2023 (Q4)
-0.20 / -0.18
-0.180.00% (0.00)
Nov 09, 2023
2023 (Q3)
-0.25 / -0.20
-0.15-33.33% (-0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CLPT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$18.23$15.81-13.27%
Aug 12, 2025
$10.54$11.92+13.09%
May 13, 2025
$14.20$12.43-12.46%
Feb 26, 2025
$17.22$14.20-17.54%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Clearpoint Neuro, Inc. (CLPT) report earnings?
Clearpoint Neuro, Inc. (CLPT) is schdueled to report earning on Mar 04, 2026, After Close (Confirmed).
    What is Clearpoint Neuro, Inc. (CLPT) earnings time?
    Clearpoint Neuro, Inc. (CLPT) earnings time is at Mar 04, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CLPT EPS forecast?
          CLPT EPS forecast for the fiscal quarter 2025 (Q4) is -0.2.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis